MacroGenics
MGNX
#9151
Rank
ยฃ84.59 M
Marketcap
ยฃ1.34
Share price
-5.18%
Change (1 day)
-45.21%
Change (1 year)

Operating Margin for MacroGenics (MGNX)

Operating Margin as of February 2026 (TTM): -59.39%

According to MacroGenics's latest financial reports and stock price the company's current Operating Margin is -59.39%. At the end of 2024 the company had an Operating Margin of -43.76%.

Operating Margin history for MacroGenics from 2013 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-43.76%228.07%
2023-13.34%-83.29%
2022-79.83%-70.12%
2021-267.20%99.31%
2020-134.06%-53.07%
2019-285.67%-2.15%
2018-291.94%1950.38%
2017-14.24%-79.47%
2016-69.35%241.44%
2015-20.31%-74.95%
2014-81.07%-12670.31%
20130.64%-95.31%
201213.76%23.3%
201111.16%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.60%-121.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
37.87%-163.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
22.91%-138.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
33.98%-157.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06%-152.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
16.72%-128.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-82.45% 38.83%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.